Evidence supporting the use of: Vitamin E
For the health condition: Macular Degeneration

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Vitamin E has been studied as part of the nutritional approach to slow the progression of Age-related Macular Degeneration (AMD), particularly in the context of the Age-Related Eye Disease Study (AREDS and AREDS2), large clinical trials conducted by the National Eye Institute. In these studies, high-dose antioxidant vitamin supplements, including vitamin E (400 IU daily), vitamin C, beta-carotene, zinc, and copper were administered to participants with intermediate or advanced AMD. The results showed that this specific combination of antioxidants and minerals slowed the progression of AMD in people at high risk of developing advanced stages. However, subsequent research indicated that vitamin E alone, or in other combinations, has not consistently demonstrated a significant benefit for AMD prevention or treatment.

The scientific rationale for including vitamin E lies in its role as a potent lipid-soluble antioxidant, which may protect retinal cells from oxidative damage—a factor believed to be involved in AMD pathogenesis. Despite its inclusion in the AREDS formula, recent reviews and meta-analyses suggest that vitamin E supplementation by itself does not significantly reduce the risk or progression of AMD. Therefore, while vitamin E is part of a scientifically validated combination therapy, its independent efficacy is limited, and the evidence for its use as a standalone treatment for AMD rates as moderate (3/5).

More about vitamin E
More about Macular Degeneration